United Therapeutics appoints Victor Dzau to Board of Directors

UNITED THERAPEUTICS Corp

Board expanded to 13 members; Victor Dzau, M.D., appointed effective July 22, 2026.
Dr. Dzau recently completed 12-year tenure as President of the National Academy of Medicine.
Initial grant: 380 RSUs and 1,190 stock options; pro-rata grant: 350 RSUs and 1,110 options.
No transactions exceeding $120,000 between Dr. Dzau and the company since last fiscal year.
Dr. Dzau will not serve on any Board committee initially.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.